We are live on ! Find out more
HCC

Hirtle Callaghan & Co Portfolio holdings

AUM $2.92B
1-Year Est. Return 17.65%
This Fund
S&P 500
This Quarter Est. Return
+3.94%
1 Year Est. Return
+17.65%
3 Year Est. Return
+46.66%
5 Year Est. Return
+38.61%
10 Year Est. Return
+120.72%
AUM
$720M
AUM Growth
+$115M
Cap. Flow
+$87.4M
Cap. Flow %
12.13%
Top 10 Hldgs %
49.83%
Holding
741
New
103
Increased
58
Reduced
70
Closed
92

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$4.25M
2
SEIC icon
SEI Investments
SEIC
+$3.29M
3
IBM icon
IBM
IBM
+$2.77M
4
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$1.3M
5
APD icon
Air Products & Chemicals
APD
+$1.07M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$26M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$6.61M
3
KMP
KINDER MORGAN ENER PNTRS L.P.
KMP
+$3.47M
4
PRF icon
Invesco FTSE RAFI US 1000 ETF
PRF
+$2.96M
5
OKS
Oneok Partners LP
OKS
+$2.04M

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.48%
2 Financials 7.1%
3 Energy 5.05%
4 Technology 4.9%
5 Healthcare 4.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXP icon
51
American Express
AXP
$223B
$1.38M 0.19%
14,495
– –
PX
52
DELISTED
Praxair Inc
PX
$1.37M 0.19%
10,308
+693
+7% +$90.8K
KDP icon
53
Keurig Dr Pepper
KDP
$40.4B
$1.36M 0.19%
23,071
– –
COP icon
54
ConocoPhillips
COP
$147B
$1.35M 0.19%
15,795
-400
-2% -$31.2K
IJH icon
55
iShares Core S&P Mid-Cap ETF
IJH
$123B
$1.35M 0.19%
+47,245
New +$1.3M
BSX icon
56
Boston Scientific
BSX
$65.8B
$1.33M 0.18%
104,047
– –
ABBV icon
57
AbbVie
ABBV
$458B
$1.31M 0.18%
23,184
– –
M icon
58
Macy's
M
$6.15B
$1.25M 0.17%
21,514
– –
IWR icon
59
iShares Russell Mid-Cap ETF
IWR
$56.8B
$1.24M 0.17%
30,568
+13,228
+76% +$516K
ADP icon
60
Automatic Data Processing
ADP
$100B
$1.22M 0.17%
17,423
– –
RDS.A
61
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.21M 0.17%
14,555
– –
APD icon
62
Air Products & Chemicals
APD
$66.3B
$1.15M 0.16%
+9,597
New +$1.07M
SHW icon
63
Sherwin-Williams
SHW
$78.3B
$1.14M 0.16%
16,593
– –
GRT
64
DELISTED
GLIMCHER REALTY TRUST
GRT
$1.13M 0.16%
103,000
– –
CMCSA icon
65
Comcast
CMCSA
$79.7B
$1.11M 0.15%
41,380
– –
WBA
66
DELISTED
Walgreens Boots Alliance
WBA
$1.08M 0.15%
14,605
– –
EL icon
67
Estee Lauder
EL
$29B
$1.04M 0.15%
14,072
– –
EWC icon
68
iShares MSCI Canada ETF
EWC
$6.04B
$1.04M 0.14%
32,100
– –
BMY icon
69
Bristol-Myers Squibb
BMY
$127B
$1.04M 0.14%
21,401
– –
PEG icon
70
Public Service Enterprise Group
PEG
$39.8B
$1.03M 0.14%
25,208
– –
NVO
71
Novo Nordisk
NVO
$216B
$1.01M 0.14%
43,800
– –
ABT icon
72
Abbott
ABT
$180B
$976K 0.14%
23,859
– –
TTE icon
73
TotalEnergies
TTE
$193B
$975K 0.14%
13,508
– –
WCN
74
Waste Connections
WCN
$42.8B
$967K 0.13%
29,880
– –
T icon
75
AT&T
T
$165B
$966K 0.13%
36,189
– –
1 2
3
4 5

Similar funds

CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
SCM
Steadfast Capital Management New York $2.92B AUM 26.34% 1-Year Est. Return
MYLI
Meiji Yasuda Life Insurance Tokyo, Japan $2.93B AUM 4.27% 1-Year Est. Return
CCM
CloudAlpha Capital Management Hong Kong $2.93B AUM 345.92% 1-Year Est. Return
BAM
BCV Asset Management Winnipeg $2.91B AUM
CWM
Calamos Wealth Management Naperville, Illinois $2.91B AUM 25.59% 1-Year Est. Return
NRCM
North Reef Capital Management Laguna Beach, California $2.91B AUM 11.03% 1-Year Est. Return
FNT
First National Trust Hermitage, Pennsylvania $2.93B AUM 22.18% 1-Year Est. Return

Hirtle Callaghan & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Hirtle Callaghan & Co held 741 positions worth $720M, up 19% from $605M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Hirtle Callaghan & Co deployed $87.4M of net new capital in Q2 2014, opening 103 new positions and adding to 58 existing holdings. Its largest new stake was Goldman Sachs: 26,355 shares worth $4.41M.

By sector, the portfolio is most concentrated in Consumer Staples at 21% of assets, down from 24% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Teledyne Technologies, an estimated $1M trimmed.

  • Hirtle Callaghan & Co's largest Q2 2014 buy was Goldman Sachs: 26,355 shares worth $4.41M.
  • Hirtle Callaghan & Co added most to iShares Russell Mid-Cap ETF in Q2 2014, an estimated $516K increase.
  • Hirtle Callaghan & Co's biggest Q2 2014 reduction was Teledyne Technologies, cutting an estimated $1M.
  • Hirtle Callaghan & Co fully exited iShares MSCI EAFE ETF in Q2 2014, selling an estimated $26M.
  • Hirtle Callaghan & Co's ten largest holdings make up 50% of its $720M portfolio in Q2 2014.
  • Hirtle Callaghan & Co opened 103 new positions and closed 92 in Q2 2014.
  • Hirtle Callaghan & Co's portfolio value rose 19% quarter-over-quarter to $720M.

Based on Hirtle Callaghan & Co's 13F filing for Q2 2014, filed 18 Jul 2014.